Geode Capital Management, LLC Senti Biosciences, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.36 - $0.66 $2,586 - $4,741	7,184 Added 3.01%	245,590 $93,000
Q3 2023 Nov 13, 2023	BUY	$0.41 - $0.99 $15,669 - $37,836	38,219 Added 19.09%	238,406 $97,000
Q4 2022 Feb 13, 2023	BUY	$1.25 - $65.2 $41,140 - $2.15 Million	32,912 Added 19.68%	200,187 $282,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $21.7 $185,072 - $3.02 Million	139,152 Added 494.8%	167,275 $362,000
Q2 2022 Aug 12, 2022	BUY	$1.97 - $10.0 $55,402 - $281,230	28,123 New	28,123 $55,000

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.